# ENDRA Life Sciences Inc.: Form SCHEDULE 13D/A, filed Jun 29, 2026

- Company: [ENDRA Life Sciences Inc.](/companies/ndra.md) (CIK 1681682)
- Form: SCHEDULE 13D/A
- Filed: 2026-06-29
- Accepted by EDGAR: Jun 29, 2026, 21:29 ET
- Period: not reported
- Accession: 0001213900-26-073318
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1681682/000121390026073318/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1681682/000121390026073318/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1681682/000121390026073318/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Jun 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-073318. Last ingested by Listed: Nov 6, 2026, 16:42 ET. No prices; not investment advice.